56 completed, 22 unknown, 11 recruiting, 8 terminated. 26 Phase 2, 25 Not applicable, 20 Phase 3, 7 Phase 4, 3 Early Phase 1.
Follow Hepatitis, Alcoholic: new trials by email Literature Review of Hepatitis, Alcoholic trials Research Report on Hepatitis, Alcoholic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A-TANGO Phase 2 Study Placebo, TAK-242, G-CSF (Filgrastim) - Acute-On-Chronic Liver Failure, Alcoholic Hepatitis | Phase 2 | Recruiting | Yaqrit Ltd | 78 | 2026-06-29 | 2026-09-21 |
| PROlonged Corticosteroid Treatment or N-ACetylcysteine for Severe Alcoholic Hepatitis N-Acetylcysteine (NAC) Treatment, Prednisolone, Placebo of N-acetylcysteine - Alcoholic Hepatitis | Phase 3 | Recruiting | University Hospital, Lille | 477 | 2026-05-22 | 2026-06-01 |
| Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH) Larsucosterol, Placebo - Hepatitis | Phase 3 | Recruiting | Bausch Health Americas, Inc. | 350 | 2026-01-29 | 2026-10-15 |
| Alcohol Consumption and Plasma cfDNA Methylation in Chronic Hepatitis B Alcohol Consumption - Chronic Hepatitis B, Alcoholic Hepatitis | Completed | Beijing Municipal Administration of Hospitals | 85 | 2025-11-21 | 2026-10-08 | |
| LiverTREM-1: Hepatic TREM-1 Expression and Prognosis in Severe Alcoholic Hepatitis TREM-1 expression (via immunohistochemistry) between SAH patients and controls - Severe Alcoholic Hepatitis | Not yet recruiting | Central Hospital, Nancy, France | 300 | 2025-10-01 | 2025-09-16 | |
| Investigating HepQuant DuO Test as a Biomarker in Alcohol-related Liver Disease HepQuant DuO Test - Alcoholic Hepatitis, Alcohol-related Liver Disease | Recruiting | HepQuant, LLC | 40 | 2025-06-10 | 2026-09-16 | |
| Short Course Steroids in Alcohol Associated Hepatitis Prednisolone 40 mg - Alcoholic Hepatitis | Phase 3 | Completed | Asian Institute of Gastroenterology, India | 151 | 2025-04-07 | 2026-09-01 |
| Randomized Controlled Trial of Mycophenolate Mofetil Versus Steroid Therapy in Alcoholic Hepatitis Mycophenolate Mofetil, Prednisone - Alcoholic Hepatitis | Not applicable | Not yet recruiting | Institute of Liver and Biliary Sciences, India | 60 | 2025-01-20 | 2025-01-23 |
| Nutritional Interventions in Patients With Alcohol-associated Hepatitis Nutritional supplement - Alcoholic Hepatitis | Not applicable | Unknown | Western University, Canada | 2000 | 2025-01-01 | 2024-05-29 |
| Recompensation in Alcohol Related Hepatitis Motivational enhancement therapy - Alcoholic Hepatitis (AH) | Not applicable | Recruiting | Nina Kimer | 160 | 2024-11-25 | 2025-02-27 |
| A Clinical Trial Investigating the Safety and Efficacy of Subjects With Alcohol Associated Hepatitis (Part 1) ADX-629 - Alcohol Hepatitis | Phase 2 | Completed | Aldeyra Therapeutics, Inc. | 4 | 2024-11-04 | 2026-06-03 |
| MRG-001 in Patients With Alcoholic Hepatitis MRG-001 - Alcoholic Hepatitis, Acute Alcoholic Hepatitis | Phase 2 | Not yet recruiting | MedRegen LLC | 32 | 2024-09-01 | 2024-03-13 |
| Intra-Hepatic Microbiota in Alcoholic Hepatitis Biological sampling - Cirrhosis, Alcoholic Liver Disease | Recruiting | Hospices Civils de Lyon | 50 | 2024-07-23 | 2026-02-10 | |
| Complex Exploratory Study of Alcohol-Associated Hepatitis Alcoholic Hepatitis | Unknown | Pavol Jozef Safarik University | 100 | 2024-05-01 | 2024-04-10 | |
| Efficacy of Plasma Exchange Therapy vs Standard Medical Therapy in Severe Alcoholic Hepatitis With High Discriminant Function Plasma Exchange, Standard Medical Treatment - Alcoholic Hepatitis | Not applicable | Unknown | Institute of Liver and Biliary Sciences, India | 60 | 2024-04-09 | 2024-06-24 |
| Integrating Care for Patients With Alcohol Liver Disease and Alcohol Use Disorders Integrated care program - Alcohol; Liver | Not applicable | Completed | University of Manitoba | 30 | 2024-04-01 | 2026-08-04 |
| Role of Extended Low Dose Prednisolone in Achieving Clinical and Biochemical Remission in Steroid Responsive Severe Alcoholic Hepatitis Prednisolone, Standard Medical therapy, Placebo - Severe Alcoholic Hepatitis | Not applicable | Unknown | Institute of Liver and Biliary Sciences, India | 150 | 2023-11-25 | 2023-12-04 |
| Safety Evaluation of Fecal Microbiota Transplantation in Severe Alcoholic Hepatitis Fecal Microbiota Transplantation, Placebo - Alcoholic Hepatitis | Phase 1 / Phase 2 | Unknown | Prasun Kumar Jalal | 50 | 2023-01-21 | 2025-01-23 |
| FXR Effect on Severe Alcohol-Associated Hepatitis (FRESH) Study INT-787, Placebo - Alcohol Associated Hepatitis | Phase 2 | Terminated | Intercept Pharmaceuticals | 67 | 2022-12-15 | 2026-05-05 |
| Utility of the Use of N-acetylcysteine Associated With Conventional Treatment in Patients With Severe Acute Alcoholic Hepatitis (Maddrey> 32) N-acetylcysteine - Alcoholic Hepatitis | Not applicable | Completed | Bioaraba Health Research Institute | 390 | 2022-10-07 | 2026-10-16 |
Showing 20 of 108. Sign in to see all of them.
Fibrosis (13) · Liver Diseases, Alcoholic (13) · Alcoholism (8) · Liver Cirrhosis, Alcoholic (7) · Hepatitis (6) · Liver Cirrhosis (5) · Liver Diseases (5) · Carcinoma, Hepatocellular (4) · Infections (4) · Acute-On-Chronic Liver Failure (3) · Ascites (3) · Hepatorenal Syndrome (3) · Inflammation (3) · Liver Failure (3)
Chemically-Induced Disorders (108) · Digestive System Diseases (108) · Substance-Related Disorders (108) · Alcohol-Induced Disorders (107) · Alcohol-Related Disorders (107) · Liver Diseases (103) · Hepatitis (102) · Liver Diseases, Alcoholic (95) · Pathologic Processes (29) · Pathological Conditions, Signs and Symptoms (29) · Infections (10) · Fibrosis (9) · Mental Disorders (9) · Hepatic Insufficiency (8) · Liver Cirrhosis (7)
Prednisolone (11) · Pentoxifylline (7) · Acetylcysteine (6) · Granulocyte Colony-Stimulating Factor (6) · Fecal Microbiota Transplantation (5) · Prednisone (4) · Adrenal Cortex Hormones (3) · Blood Specimen Collection (3) · Ethanol (3) · Methylprednisolone (3) · 3-(2-(2-tert-butylphenylaminooxalyl)aminopropionylamino)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid (2) · Ascorbic Acid (2) · Filgrastim (2) · Hepatitis A Vaccines (2) · Interleukin 1 Receptor Antagonist Protein (2)
Institute of Liver and Biliary Sciences, India (9) · University Hospital, Lille (6) · Post Graduate Institute of Medical Education and Research, Chandigarh (5) · University of Aarhus (5) · Indiana University (4) · Erasme University Hospital (3) · University of Alabama at Birmingham (3) · Asian Institute of Gastroenterology, India (2) · Chuncheon Sacred Heart Hospital (2) · Conatus Pharmaceuticals Inc. (2) · Dayanand Medical College and Hospital (2) · Durect (2) · HepQuant, LLC (2) · Imperial College London (2) · Johns Hopkins University (2)
United States (36) · India (18) · France (14) · United Kingdom (10) · Belgium (7) · Denmark (7) · South Korea (4) · Spain (4) · Canada (3) · Zambia (3) · Austria (2) · China (2) · Germany (2) · Mexico (2) · Slovakia (2)
Michael J Vinikoor, MD (3) · Christophe Moreno, MD, PhD (2) · Naga Chalasani, MD (2) · Santiago Tome, MD (2) · . Prasanna Samuel Premkumar, PhD (1) · Ajay C Dusseja, DM (1) · Ajay Duseja, DM (1) · Alexander Kuo, MD (1) · Alexandre Louvet, MD,PhD (1) · Ali R Ahmadi, MD PhD (1) · Andres Duarte-Rojo, MD (1) · Andrew M Cameron, MD, PhD (1)
PMID 37011138, PMID 16026887, PMID 19553649, PMID 31811953, PMID 38215876, PMID 10782906, PMID 11113085, PMID 11172350, PMID 11605686, PMID 11943418, PMID 14647046, PMID 14653766, PMID 15122768, PMID 1531090, PMID 15349802, PMID 15618643, PMID 15763232, PMID 16009691, PMID 17204261, PMID 17518367, PMID 1828447, PMID 18721242, PMID 19340904, PMID 19445945, PMID 19821406, PMID 20334708, PMID 21085006, PMID 2142869, PMID 22070475, PMID 22388710, PMID 22633836, PMID 22821948, PMID 23029716, PMID 23101983, PMID 2358784, PMID 23737845, PMID 23855300, PMID 23870864, PMID 24026598, PMID 24029409, PMID 24523762, PMID 24704590, PMID 24766056, PMID 25009371, PMID 25154291, PMID 25501547, PMID 25901427, PMID 25945012, PMID 26275112, PMID 26288026
P50AA027054 (2), U01AA021788 (2), U01AA021840 (2), U01AA021886 (2), U01AA021891 (2), U01AA021893 (2), 2004 (1), 2014 (1), 2016 (1), 2025 (1), K01TW009998 (1), R21AA014269 (1), U01AA021883 (1), U01AA021908 (1), U01AA026934 (1)